The Global Bioglass Market was valued at USD 842.5 million in 2024 and is projected to reach USD 1.64 billion by 2032, growing at a Compound Annual Growth Rate (CAGR) of 9.2% during the forecast period (2025–2032). This growth is being driven by rising demand for bone graft substitutes in orthopedic and dental applications, technological advancements in bioactive scaffolds, and expanding use in wound healing and cosmeceuticals across healthcare sectors.

As the regenerative medicine field advances toward bioactive solutions and tissue engineering, the spotlight is on the key bioglass manufacturers driving innovation, clinical efficacy, and advanced material science. In this blog, we profile the Top 10 Companies in the Global Bioglass Industry—a mix of established glass specialists, biotech innovators, and medical device leaders shaping the future of bone regeneration and beyond.

---

🔟 1. Dingsheng Biology

Headquarters: China
Key Offering: Bioactive glass powders, scaffolds for bone repair

Dingsheng Biology is a rising force in Asia’s bioglass sector, supplying bioactive glass materials tailored for orthopedic implants and dental regeneration. The company focuses on high-bioactivity formulations suitable for emerging markets, supporting local healthcare needs with cost-effective solutions that promote osseointegration in bone defect treatments.

Innovation Initiatives:

• Development of custom bioglass composites for Asian regulatory standards

• Partnerships with hospitals for clinical trials in dental applications

• Expansion into particulate forms for minimally invasive procedures

Download FREE Sample Report: Global Bioglass Market – View in Detailed Research Report

---

9️⃣ 2. Synergy Biomedical

Headquarters: Rochester, New York, USA
Key Offering: SB5X borate bioactive glass, bone void fillers

Synergy Biomedical specializes in borate-based bioglass products like SB5X, which degrade faster than traditional silicate glasses to stimulate angiogenesis and bone growth. Their materials are used in orthopedic surgeries for treating infections and complex fractures, with a focus on converting to hydroxyapatite in vivo.

Innovation Initiatives:

• Clinical studies on borate glass for osteomyelitis treatment

• Antibacterial properties reducing post-op infections

---

8️⃣ 3. Bonalive Biomaterials Ltd.

Headquarters: Turku, Finland
Key Offering: Bonalive S53P4 bioglass granules, pastes

Bonalive is renowned for its S53P4 bioactive glass, the first bioglass approved for treating chronic osteomyelitis in the EU. Serving orthopedic and trauma surgery, their products release ions to kill bacteria and bond with bone, used in over 100,000 procedures worldwide.

Innovation Initiatives:

• Regulatory approvals in Europe and US for bone infection voids

• Research on combining with antibiotics for enhanced efficacy

---

7️⃣ 4. Mo-Sci Corporation

Headquarters: Rolla, Missouri, USA
Key Offering: Custom bioactive glass fibers, powders, scaffolds

Mo-Sci leads in tailored bioglass solutions for research and clinical use, offering phosphate and borate glasses for tissue engineering. They collaborate with universities and device makers to develop next-gen scaffolds that support cell growth in regenerative applications.

Innovation Initiatives:

• Advanced 3D printing of bioglass for patient-specific implants

• Focus on controlled degradation for drug delivery systems

Download FREE Sample Report: Global Bioglass Market – View in Detailed Research Report

---

6️⃣ 5. Ferro Corporation

Headquarters: Mayfield Heights, Ohio, USA
Key Offering: Bioactive glass powders for composites, cements

Ferro provides specialty bioglass powders integrated into bone cements and coatings, enhancing bioactivity in dental and orthopedic devices. Their materials improve implant integration by forming strong bonds with surrounding tissue through hydroxyapatite layer formation.

Innovation Initiatives:

• High-volume production of bioactive frits for medical composites

• Collaborations for cosmeceutical-grade bioglass particles

---

5️⃣ 6. Dolph Ltd

Headquarters: Oldbury, United Kingdom
Key Offering: NovaMin bioactive glass for dental remineralization

Dolph Ltd markets NovaMin technology, a 45S5-like bioglass used in toothpastes and dental treatments for hypersensitivity relief and enamel repair. It releases calcium, phosphate, and silica ions to form a mineral layer mimicking natural tooth structure.

Innovation Initiatives:

• Integration into oral care products for daily regeneration

• Clinical data supporting dentin tubule occlusion

---

4️⃣ 7. SCHOTT AG

Headquarters: Mainz, Germany
Key Offering: Bioactive glass tubing, powders for implants

SCHOTT AG excels in precision bioactive glasses for pharmaceutical and medical applications, including vascular stents and bone substitutes. Their expertise in glass melting and forming ensures consistent bioactivity for demanding clinical environments.

Innovation Initiatives:

• Advanced glass-ceramics for load-bearing bone repair

• Sustainable manufacturing processes for medical-grade materials

Download FREE Sample Report: Global Bioglass Market – View in Detailed Research Report

---

3️⃣ 8. US Biomaterials Corporation

Headquarters: Alachua, Florida, USA
Key Offering: PeriOgGlas, Bio-Active Glass for periodontal regeneration

US Biomaterials pioneered commercial 45S5 bioglass with products like PeriOgGlas for dental bone grafting. Widely used in periodontics, it supports new bone and cementum formation, established through decades of clinical success.

Innovation Initiatives:

• Long-term studies validating 45S5 for dental defects

• Expansion to orthopedic putties and granules

---

2️⃣ 9. Stryker Corporation (NovaBone)

Headquarters: Kalamazoo, Michigan, USA
Key Offering: NovaBone Putty, CMS bone graft substitutes

Stryker’s NovaBone division offers bioglass-based synthetic bone grafts for trauma and spine surgery. Their putties mold easily and resorb predictably, promoting natural bone ingrowth without donor site morbidity.

Innovation Initiatives:

• FDA-cleared products for dental and orthopedic voids

• Integration with biologics for enhanced regeneration

---

1️⃣ 10. Bonalive Biomaterials Ltd.

Headquarters: Turku, Finland
Key Offering: S53P4 bioglass for infection control, bone voids

Bonalive tops the list with its clinically proven S53P4 bioglass, unique for intrinsic antibacterial action in treating osteomyelitis. Deployed globally in hospitals, it eliminates the need for systemic antibiotics in many cases, revolutionizing infection management.

Innovation Initiatives:

• World’s first bioglass CE-marked for osteomyelitis

• Ongoing trials for cavitary osteomyelitis and spine applications

• Strategic expansions into North America and Asia

Read Full Report: Global Bioglass Market – View in Detailed Research Report

---

🌍 Outlook: The Future of Bioglass Is More Bioactive and Regenerative

The bioglass market is undergoing a transformative evolution. While orthopedic and dental uses dominate, the industry is channeling resources into composites, wound care, and cosmeceuticals for broader therapeutic impact.

📈 Key Trends Shaping the Market:

• Rapid development of borate and phosphate glasses for faster healing

• Regulatory expansions for antibacterial bioglass in chronic infections

• 3D printing and scaffolds for customized tissue engineering

• Geographic push into Asia-Pacific for high-volume adoption

Read Full Report: Global Bioglass Market – View in Detailed Research Report

The companies listed above are not only supplying bioactive materials—they’re spearheading the regenerative medicine transition.